Literature DB >> 1439665

Methods for the study of calcium oxalate crystallisation and their application to urolithiasis research.

J P Kavanagh1.   

Abstract

Many methods have been used to study calcium oxalate crystallisation. Most can be characterised by changes in supersaturation during the experiment, which may increase, remain constant or decay. Their ability to quantify various aspects of crystallisation often reflects the extent to which nucleation, growth and aggregation can be measured independently, when two or three of these processes may be occurring simultaneously. The mixed suspension, mixed product removal technique reaches a steady state supersaturation, is a good model for intrarenal crystallisation and allows both growth and nucleation rates to be measured. Using 92% urine and comparing control urines with samples from recurrent stone formers no difference in growth rates was found but the controls had higher nucleation rates (p = 0.003) and lower supersaturations (p = 0.001). In parallel crystallisers running simultaneously, heparin or hyaluronic acid addition to 92% urine was studied. Both macromolecules increased growth rates, decreased nucleation rates and increased supersaturation (p < 0.05). The steady state supersaturation achieved in this system may be an important determinant of stone forming potential. The ability to reach a lower urinary supersaturation by increased nucleation may be a crucial protective factor distinguishing non stone formers from stone formers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1439665

Source DB:  PubMed          Journal:  Scanning Microsc        ISSN: 0891-7035


  10 in total

1.  A stone farm: development of a method for simultaneous production of multiple calcium oxalate stones in vitro.

Authors:  K Chow; J Dixon; S Gilpin; J P Kavanagh; P N Rao
Journal:  Urol Res       Date:  2003-10-22

Review 2.  In vitro calcium oxalate crystallisation methods.

Authors:  John P Kavanagh
Journal:  Urol Res       Date:  2006-01-14

3.  Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth.

Authors:  Dawn Webber; Allen L Rodgers; Edward D Sturrock
Journal:  Urol Res       Date:  2007-11-07

4.  Automated and computer-controlled method for the measurement of the crystallization of calcium oxalate monohydrate in urine.

Authors:  D Tassile; B Affolter; J M Baumann; H P Siegrist; H J Keller
Journal:  Urol Res       Date:  1995

5.  In vitro crystallisation systems for the study of urinary stone formation.

Authors:  W Achilles
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

6.  Reverse engineering the kidney: modelling calcium oxalate monohydrate crystallization in the nephron.

Authors:  A Borissova; G E Goltz; J P Kavanagh; T A Wilkins
Journal:  Med Biol Eng Comput       Date:  2010-04-28       Impact factor: 2.602

7.  Effects of trace metals on the inhibition of calcium oxalate crystallization.

Authors:  J A Muñoz; M Valiente
Journal:  Urol Res       Date:  2005-06-04

8.  Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist?

Authors:  A L Rodgers; D Webber; B Hibberd
Journal:  Urolithiasis       Date:  2015-07-22       Impact factor: 3.436

9.  Nucleation of calcium oxalate crystals on an imprinted polymer surface from pure aqueous solution and urine.

Authors:  Timothy J Egan; Allen L Rodgers; Tewolde Siele
Journal:  J Biol Inorg Chem       Date:  2004-01-13       Impact factor: 3.358

10.  Herbal preparations affect the kinetic factors of calcium oxalate crystallization in synthetic urine: implications for kidney stone therapy.

Authors:  Allen L Rodgers; Dawn Webber; Ronica Ramsout; Mayur Danny I Gohel
Journal:  Urolithiasis       Date:  2014-03-20       Impact factor: 3.436

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.